Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 856 | 1,217 | N/A |
| TOTAL | $1,206 | $1,627 | $N/A |
| Non-Current Assets | |||
| Investments And Advances | 138,009 | 138,005 | 0 |
| TOTAL | $138,009 | $138,005 | $N/A |
| Total Assets | $139,215 | $139,631 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | 6 | N/A |
| Accrued Expenses | 209 | 390 | N/A |
| TOTAL | $209 | $396 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 151,914 | 152,032 | 0 |
| TOTAL | $151,914 | $152,032 | $N/A |
| Total Liabilities | $152,123 | $152,428 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 17,250 | 17,250 | N/A |
| Retained earnings | -12,909 | -12,797 | N/A |
| TOTAL | $-12,909 | $-12,797 | $N/A |
| Total Liabilities And Equity | $139,215 | $139,631 | $0 |